Search Results
10
Everything
Search Filters
Organization
Bionical Emas
Bionical Emas sells EMAS Pharma to Kester Capital following strategic review
December 09, 2024 02:00 ET
|
Bionical Emas
Bionical Emas, the Early Access Programs and Clinical Trial Supply business, is selling EMAS Pharma to Kester Capital and an incoming executive team.